PTAB not such a "death squad", at least for Orange Book pharma patents, study suggests

A new US Patent and Trademark Office (USPTO) study has provided an improved insight into the outcomes of administrative validity challenges made against Orange Book-listed pharmaceutical patents at the Patent Trial and Appeal Board (PTAB). Among…

Unlock unlimited access to all IAM content